PRECIGEN, INC.·4

Mar 20, 7:21 PM ET

Shah Rutul R 4

4 · PRECIGEN, INC. · Filed Mar 20, 2026

Research Summary

AI-generated summary of this filing

Updated

Precigen (PGEN) COO Rutul Shah Receives 44,495 RSU Award & Converts

What Happened

  • Rutul R. Shah, Chief Operating Officer of Precigen (PGEN), was granted 44,495 restricted stock units (RSUs) on March 18, 2026. The RSUs vested immediately and converted into 44,495 shares (transaction code M). The grant and conversion are reported at $0.00 (compensation/derivative award), and a simultaneous disposition of 44,495 shares is also reported at $0.00.

Key Details

  • Transaction date: March 18, 2026; Form 4 filed March 20, 2026 (timely within the standard reporting window).
  • Shares involved: 44,495 RSUs granted and vested; 44,495 shares acquired by conversion and 44,495 shares reported disposed.
  • Prices/values: Grant and conversion reported at $0.00 (award/derivative compensation); total cash amount reported = $0.
  • Shares owned after transaction: Not disclosed in the provided excerpt of the filing.
  • Footnotes: F1 — each RSU represents a contingent right to one share of Precigen common stock; F2 — the RSUs vested immediately upon grant.
  • No 10b5-1 plan or late filing flag indicated in the provided data.

Context

  • This appears to be a compensation-related grant that vested and converted to shares; the immediate disposition reported at $0.00 is commonly seen when shares are net-settled or withheld to cover taxes or other obligations rather than an open-market sale. Such transactions are routine for executive compensation and do not, by themselves, indicate a buy or sell sentiment toward the company stock.

Insider Transaction Report

Form 4
Period: 2026-03-18
Shah Rutul R
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-03-18+44,495450,454 total
  • Award

    Restricted Stock Units

    [F1][F2]
    2026-03-18+44,49544,495 total
    Common Stock (44,495 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F1][F2]
    2026-03-1844,4950 total
    Common Stock (44,495 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
  • [F2]The RSUs vested immediately upon the grant date.
Signature
/s/ Rutul R. Shah, by Donald P. Lehr, as attorney-in-fact|2026-03-20

Documents

1 file
  • 4
    dp243984_4-shah.xmlPrimary

    FORM 4